Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/06/2005WO2005014641A3 Ciliary neurotrophic factor variants
10/06/2005WO2005007877A3 Regulatable promoters for synthesis of small hairpin rna
10/06/2005WO2005000884A8 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
10/06/2005WO2004113386A3 Modified hirudin proteins and t-cell epitopes in hirudin
10/06/2005WO2004093787A3 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
10/06/2005WO2004084800A3 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
10/06/2005WO2004080406A3 Therapeutic compositions
10/06/2005WO2004069207A3 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
10/06/2005WO2004042000A3 157 human secreted proteins
10/06/2005US20050223438 Functional plant, promoter to be used for producing the functional plant and method of using the same
10/06/2005US20050223434 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
10/06/2005US20050223433 Cobra gene and uses thereof
10/06/2005US20050223432 ODP2 promoter and methods of use
10/06/2005US20050223430 Gntiii expression in plants
10/06/2005US20050223424 Compositions and methods for altering amino acid content or proteins
10/06/2005US20050223420 Inducible heart attack animal model
10/06/2005US20050223417 Germ line and somatic cells comprising a mutant p27kip1 protein lacking a Cdk2 phosphorylation site; side effect reduction
10/06/2005US20050223416 C1 inhibitor produced in the milk of transgenic mammals
10/06/2005US20050222402 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/06/2005US20050222400 Aptamer constructs
10/06/2005US20050222394 Have a hydrophobic linker region and a heparin-binding region, useful as soluble biologics or as surface coatings for medical devices
10/06/2005US20050222393 Chemokine receptor obtained from a cdna library of fetal liver-spleen
10/06/2005US20050222391 Method of constructing antibody
10/06/2005US20050222390 The peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases
10/06/2005US20050222389 Method for preparing modified polypeptides
10/06/2005US20050222388 Fusion protein of hiv regulatory/accessory proteins
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222386 Biomolecule transduction motif sim-2-btm and the use thereof
10/06/2005US20050222385 Hybrid and tandem expression of neisserial proteins
10/06/2005US20050222384 Useful as prophylactic and therapeutic agent of dysfunction of masticatory, dysphagia, dysgeusia, ozostomia, intra-oral cavity dysphoria, intra-oral cavity infections, intra-oral cavity inflammations, dry eye, ectocornea detachment, keratitis, corneal ulcer, conjunctivitis, stomach and duodenal ulcers
10/06/2005US20050222383 Prostasin substrates and inhibitors
10/06/2005US20050222070 Pancreas-specific proteins
10/06/2005US20050222069 Optimization of immunomodulatory properties of genetic vaccines
10/06/2005US20050222067 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell
10/06/2005US20050222062 Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
10/06/2005US20050222042 Modifying N-methyl-D-aspartate function without completely blocking the receptor or adversely affecting other neuronal proteins with the use of generalized kinase inhibitors with an oligopeptide that inhibits interaction of the unique domain of the tyrosine kinase Src enzyme and the receptor complex
10/06/2005US20050222041 oligopeptides capable of stimulating neural cell adhesion molecule (NCAM) signalling and/or interfering with cell adhesion, used for treatment of nervous system disorders
10/06/2005US20050222037 Modulates cell adhesion, angiogenesis, maintenance of vascular integrity, regulation of vascular permeability
10/06/2005US20050222036 Peptide compositions with effects on blood glucose
10/06/2005US20050222035 Peptides and related molecules that modulate nerve growth factor activity
10/06/2005US20050222033 Receptor based antagonists and methods of making and using
10/06/2005US20050222032 Polynucleotide and polypeptide molecules for zacrp2, a novel member of the family of proteins bearing a collagen-like domain and a C1q domain
10/06/2005US20050222030 Modified annexin proteins and methods for preventing thrombosis
10/06/2005US20050222029 Compositions and methods for treating diseases
10/06/2005US20050222026 Purified nitrosylated albumin variant of an amino acid sequence of human serum albumin; antimicrobial
10/06/2005US20050222023 Albumin-fused kunitz domain peptides
10/06/2005US20050222021 Immunomodulators; for treatment of inflammation
10/06/2005US20050222020 Apoptotically active peptides
10/06/2005US20050222019 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
10/06/2005US20050222018 Isolated human ras- like proteins, nucleic acid molecules encoding these human ras-like proteins , and uses thereof
10/06/2005US20050222017 Apoptosis promoter and inhibitor interacting with cgi-94, and method of screening the same
10/06/2005US20050222014 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture
10/06/2005US20050222011 Selectin ligands
10/06/2005US20050222009 Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier
10/06/2005US20050221489 Recombinant negative strand virus rna expression systems and vaccines
10/06/2005US20050221488 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods
10/06/2005US20050221487 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
10/06/2005US20050221477 Protein sustaining undifferentiated stem cells as such
10/06/2005US20050221474 Gene promoters
10/06/2005US20050221463 Novel human thymosin protein and polynucleotides encoding the same
10/06/2005US20050221460 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
10/06/2005US20050221450 Methods of making L-amino acids in coryneform bacteria using the sigE gene
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221444 Expression cassette comprising a polypeptide with a promoter sequence, a translation initiation sequence, a first inclusion body fusion partner, suppressable stop codon,cleavable peptide linkers, a fusion tag, and a transcription terminator sequence; antidiabetic agents; viral infections
10/06/2005US20050221443 Tumor necrosis factor super family agonists
10/06/2005US20050221442 Bacterial host cell for the direct expression of peptides
10/06/2005US20050221441 Protein has N terminal hairpin domain and subsequent four kringle domains; hepatocyte growth factor antagonists; angiogenesis inhibitors; deletion or substitution mutants; antitumor and antimetastatic biodrugs
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221439 Genes of an otitis media isolate of haemophilus influenzae
10/06/2005US20050221438 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for grafting enhancement, graft versus host (GvH) inhibition, graft versus tumor (GvT) stimulation, for the prevention or therapy of tumors and/or of microorganism infections
10/06/2005US20050221437 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/06/2005US20050221436 Human neuropeptide Y-like G protein-coupled receptor
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221433 IL-18 specific polypeptides and therapeutic uses thereof
10/06/2005US20050221432 Altering the cellular secretion rate of a protein comprising the steps of modulating the activity of at least one UPR pathway component in a cell and culturing the cell; useful for producing high levels of proteins for therapeutic, diagnostic or research purposes
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
10/06/2005US20050221428 Chimeric neuropeptide Y receptors
10/06/2005US20050221426 Polynucleotide having a sequence encoding a mutant cyclic nucleotide-gated channel with at least one mutation that decreases divalent cation-mediated blockage of cation flux; and at least one mutation that makes the channel more sensitive to cAMP than a channel that does not have the mutation
10/06/2005US20050221425 promoter is induced by a reduction in temperature; can be used for regulated expression of proteins, both homologous and heterologous, very efficiently and economically
10/06/2005US20050221423 Bacillus host cell
10/06/2005US20050221421 Method of producing and using heat shock proteins
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221404 Infective aggregating forms of proteins such as PrP, amyloid, and tau are bound selectively in the presence of the normal form protein using protease resistant binding agents such as dextran sulphate or pentosan
10/06/2005US20050221402 Bacterial small-molecule three-hybrid system
10/06/2005US20050221400 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
10/06/2005US20050221395 Methods and products based on oligomerization of stress proteins
10/06/2005US20050221394 Ion channel
10/06/2005US20050221391 Reagents and methods for identification of binding agents
10/06/2005US20050221388 Molecular interactions in hematopoietic cells
10/06/2005US20050221384 Combinatorial libraries of monomer domains
10/06/2005US20050221381 Method for isolating ligands
10/06/2005US20050221372 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
10/06/2005US20050221371 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/06/2005US20050221359 Cospeptin, cosmedin and their uses
10/06/2005US20050221352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/06/2005US20050221347 Inhibitors of binding between proteins and macromolecular ligands
10/06/2005US20050221345 Thioredoxin h homologs
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221343 Self-assembling split-fluorescent protein systems
10/06/2005US20050221342 Nucleic acids and polypeptides
1 ... 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 ... 2916